Top Ten most popular articles on Pharmafile.com this week
pharmafile | July 10, 2020 | News story | Medical Communications | coronavirus, covid19, top 10
The World Health Organization features prominently in the news this week, as it discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments, while 239 scientists from over 30 countries urged the WHO to put more focus on assessing the possible airborne spread of the virus.
In other news, the Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has been infected while Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company.
1. Florida issues warning over ‘brain-eating’ amoeba
The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has been infected.
The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any region which began to show an uncontrolled rise in COVID-19 cases.
3. COVID-19 immunity may be more widespread than previously thought, new study suggests
Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative for antibodies, a new study suggests.
4. Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part of their BNT162 RNA-based COVID-19 vaccine programme known as Project Lightspeed, showing that it successfully generated immune response in healthy patients.
5. WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir
The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments.
6. Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine
Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly others, to help scale up manufacture of its potential COVID-19 vaccine.
7. UK universities join forces for early-stage COVID-19 therapy testing platform
A coalition of UK universities have come together to build a new clinical trial and drug testing platform to evaluate early efficacy of potential therapies for the treatment of COVID-19, it has been announced.
8. Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients
European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter 2 (SGLT2) inhibitor to be approved in Europe to treat diabetic kidney disease (DKD) in type 2 diabetes (T2DM) patients.
9. Scientists urge World Health Organization to reconsider stance on COVID-19 airborne spread
239 scientists from over 30 countries are urging the World Health Organization to put more focus on assessing the possible airborne spread of COVID-19.
10. Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer
Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He was 65.
Conor Kavanagh
Related Content
Valneva COVID-19 vaccine deal pulled by UK government
Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva …
Pharmafile.com’s top 10 news stories of the week
Among our ten most-read stories this week: NICE has announced that more patients are eligible …
Pharmafile.com’s weekly COVID-19 news round-up
The past week has continued to see positive COVID-19 news; CytoDyn’s treatment for patients with …
